Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 25 results.
User Information
Export Records
  1. 1.   SNARE mimicry by the CD225 domain of IFITM3 enables regulation of homotypic late endosome fusion
  2. Rahman, Kazi; Wilt,Isaiah; Jolley, Abigail A; Chowdhury,Bhabadeb; Datta, Siddhartha A K; Compton,Alex
  3. The EMBO Journal. 2024, Dec 09;
  1. 2.   Sequential requirements for the GTPase domain of the mitofusin Fzo1 and the ubiquitin ligase SCF(Mdm30) in mitochondrial outer membrane fusion
  2. Cohen, M. M.; Amiott, E. A.; Day, A. R.; Leboucher, G. P.; Pryce, E. N.; Glickman, M. H.; McCaffery, J. M.; Shaw, J. M.; Weissman, A. M.
  3. Journal of Cell Science. 2011, May; 124(9): 1403-1410.
  1. 3.   Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain
  2. Wexler-Cohen, Y.; Ashkenazi, A.; Viard, M.; Blumenthal, R.; Shai, Y.
  3. Faseb Journal. 2010, Nov; 24(11): 4196-4202.
  1. 4.   Sphingolipids, cholesterol, and HIV-1: A paradigm in viral fusion
  2. Rawat, S. S.; Viard, M.; Gallo, S. A.; Blumenthal, R.; Puri, A.
  3. Glycoconjugate Journal. 2006, MAY; 23(3-4): 189-197.
  1. 5.   Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies
  2. Zhu, Z. Y.; Dimitrov, A. S.; Bossart, K. N.; Crameri, G.; Bishop, K. A.; Choudhry, V.; Mungall, B. A.; Feng, Y. R.; Choudhary, A.; Zhang, M. Y.; Feng, Y.; Wang, L. F.; Xiao, X. D.; Eaton, B. T.; Broder, C. C.; Dimitrov, D. S.
  3. Journal of Virology. 2006, JAN; 80(2): 891-899.
  1. 6.   Sphingolipids: Modulators of HIV-1 infection and pathogenesis
  2. Rawat, S. S.; Johnson, B. T.; Puri, A.
  3. Bioscience Reports. 2005, OCT; 25(5-6): 329-343.
  1. 7.   Inhibition of HIV-1 envelope glycoprotein-mediated cell fusion by a DL-amino acid-containing fusion peptide - Possible recognition of the fusion complex
  2. Gerber, D.; Pritsker, M.; Gunther-Ausborn, S.; Johnson, B.; Blumenthal, R.; Shai, Y.
  3. Journal of Biological Chemistry. 2004, NOV 12; 279(46): 48224-48230.
  1. 8.   The SARS-CoV S glycoprotein
  2. Xiao, X.; Dimitrov, D. S.
  3. Cellular and Molecular Life Sciences. 2004, OCT; 61(19-20): 2428-2430.
  1. 9.   Oligomerization of the SARS-CoV S glycoprotein: dimerization of the N-terminus and trimerization of the ectodomain
  2. Xiao, X. D.; Feng, Y.; Chakraborti, S.; Dimitrov, D. S.
  3. Biochemical and Biophysical Research Communications. 2004, SEP 10; 322(1): 93-99.
  1. 10.   Alterations in dsu expression results in abnormal photoreceptor morphology, implications for membrane fusion
  2. Boesze-Battaglia, K.; Rachel, R. A.; Copeland, N. G.; mek-Poprawa, M.; Jenkins, N.
  3. Investigative Ophthalmology & Visual Science. 2004, APR; 45(Suppl. 2): 3625, U181-3625, U181.
  1. 11.   An inhibitor of glycosphingolipid metabolism blocks HIV-1 infection of primary T-cells
  2. Puri, A.; Rawat, S. S.; Lin, H. M. J.; Finnegan, C. A.; Mikovits, J.; Ruscetti, F. W.; Blumenthal, R.
  3. Aids. 2004 18(6): 849-858.
  1. 12.   Functional expression of CD4, CXCR4, and CCR5 in glycosphingolipid-deficient mouse melanoma GM95 cells and susceptibility to HIV-1 envelope glycoprotein-triggered membrane fusion
  2. Rawat, S. S.; Eaton, J.; Gallo, S. A.; Martin, T. D.; Ablan, S.; Ratnayake, S.; Viard, M.; KewalRamani, V. N.; Wang, J. M.; Blumenthal, R.; Puri, A.
  3. Virology. 2004 318(1): 55-65.
  1. 13.   The C- and the N-terminal regions of glycoprotein 41 ectodomain fuse membranes enriched and not enriched with cholesterol, respectively
  2. Shnaper, S.; Sackett, K.; Gallo, S. A.; Blumenthal, R.; Shai, Y.
  3. Journal of Biological Chemistry. 2004 279(18): 18526-18534.
  1. 14.   The role of glycosphingolipids in HIV signaling, entry and pathogenesis
  2. Viard, M.; Parolini, I.; Rawat, S. S.; Fecchi, K.; Sargiacomo, M.; Puri, A.; Blumenthal, R.
  3. Glycoconjugate Journal. 2003 20(3): 213-222.
  1. 15.   Quantitative measurement of fusion of HIV-1 and SIV with cultured cells using photosensitized labeling
  2. Raviv, Y.; Viard, M.; Bess, J.; Blumenthal, R.
  3. Virology. 2002 293(2): 243-251.
  1. 16.   Fluorescent lipid probes in the study of viral membrane fusion
  2. Blumenthal, R.; Gallo, S. A.; Viard, M.; Raviv, Y.; Puri, A.
  3. Chemistry and Physics of Lipids. 2002 116(1-2, Special Issue): 39-55.
  1. 17.   Membrane-induced conformational change during the activation of HIV-1 gp41
  2. Kliger, Y.; Peisajovich, S. G.; Blumenthal, R.; Shai, Y.
  3. Journal of Molecular Biology. 2000 301(4): 905-914.
  1. 18.   P-glycoprotein-overexpressing multidrug-resistant cells are resistant to infection by enveloped viruses that enter via the plasma membrane
  2. Raviv, Y.; Puri, A.; Blumenthal, R.
  3. Faseb Journal. 2000 14(3): 511-515.
  1. 19.   A mechanism of resistance to HIV-1 entry: Inefficient interactions of CXCR4 with CD4 and gp120 in macrophages
  2. Dimitrov, D. S.; Norwood, D.; Stantchev, T. S.; Feng, Y. R.; Xiao, X. D.; Broder, C. C.
  3. Virology. 1999 259(1): 1-6.
  1. 20.   Dual effect of IL-4 on HIV-1 expression: implications for viral phenotypic switch and disease progression
  2. Pavlakis, G. N.; Valentin, A.; Lu, W.; Rosati, M.; Schneider, R.
  3. Conference on Retroviruses and Opportunistic Infections. 1998, 223 (abstract no. LB1).
  1. 21.   A distamycin analog selectively blocks chemokine receptor function and HIV-1 fusion
  2. Turpin, J. A.; Rice, W. G.; Oppenheim, J. J.; Hollingshead, M. G.; Covey, J. M.; Howard, O. M.
  3. HIV Pathogenesis and Treatment Conference. 1998, 57 (abstract no. 2042).
  1. 22.   Influenza virus-assisted entry of a TCL-tropic HIV-1 isolate into CD4+ cells
  2. Puri, A.; Carroll, R.; Riley, J.; Hug, P.; Jernigan, K.; Blumenthal, R.
  3. Keystone Symposia on Molecular and Cellular Biology. 1998, 114 (abstract no. 109).
  1. 23.   Identification of potential HIV-1 integrase (IN) inhibitors by co-localization of antiviral activity with integrase mediated events in the retroviral replication cycle
  2. Rice, W. G.; Schaeffer, C. A.; Bu, M.; Williamson, K.; Turpin, J. A.
  3. HIV Pathogenesis and Treatment Conference. 1998, 55 (abstract no. 2036).
  1. 24.   New types of anti-HIV agents identified by the NCI drug discovery program. Eleventh International Conference on Antiviral Research
  2. Rice, W. G.; Turpin, J. A.; Huang, M.; Howard, O. M.; Michejda, C. J.; Bader, J. P.
  3. Antiviral Research. 1998 37(3): A58 (abstract no. 64).
  1. 25.   Hiv Coreceptors
  2. Dimitrov, D. S.; Xiao, X.; Chabot, D. J.; Broder, C. C.
  3. Journal of Membrane Biology. 1998 166(2): 75-90.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel